Chrysaor Biologics is an agile DNA vaccine company that is working on several candidate vaccines that are designed in house. Chrysaor is looking for partnerships in vaccine development to better establish these novel vaccines in the marketplace. Chrysaor is based out of Atlantic Canada and was incorperated in 2024. Chrysaor utilizes the BPE DNA platform invented and owned by Pegasus biotech.